BOK Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,630
Closed -$212K 925
2018
Q1
$212K Buy
+4,630
New +$212K 0.01% 846